Heska Corp. - Ordinary Shares (Restricted Voting)

NASDAQ:HSKA  
177.27
+4.30 (+2.49%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.89B
Current PEN/A
Forward PE N/A
2yr Forward PE 196.97
See more stats
Estimates Current Quarter
Revenue$52.45 Million
Adjusted EPS-$0.32
See more estimates
10-Day MA$172.95
50-Day MA$182.71
200-Day MA$133.01
See more pivots

Heska Corp. Stock, NASDAQ:HSKA

3760 Rocky Mountain Avenue, Loveland, Colorado 80538
United States of America
Phone: +1.970.493.7272
Number of Employees: 386

Description

Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through two segments: Core Companion Animal Health and Other Vaccines & Pharmaceuticals. The Core Companion Animal Health segment includes point of care diagnostic laboratory instruments and supplies, imaging instruments, software, and services as well as single use diagnostic and other tests, pharmaceuticals, and vaccines. The Other Vaccines & Pharmaceuticals segment focuses on private label vaccine and pharmaceutical production, primarily for cattle, but also for equine, porcine, avian, feline, and canine. Heska was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.